An adolescent-mediated intervention to improve diabetes prevention and management in pacific islander families

NCT ID NCT05356884

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Oct 22, 2026 · Last updated Oct 23, 2026 · Updated 1 time

Summary

The goal of this project is to test the feasibility, acceptability, and preliminary efficacy of an adolescent-mediated intervention designed to improve the glycemic control and self-care practices of a parent/grandparent. The preliminary impact of the intervention on adult glycemic control (HbA1c) and self-care behaviors, as well as adolescent risk factors, will be explored with the goal of informing future programs that can be scaled to reduce diabetes burden and eliminate health disparities among at risk, ethnic minority groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

360 people

The number who actually took part.

Started

Jul 2022

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

14 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Adolescent * 14-17 years of age * Samoan ethnicity * Shares a household with a parent, legal guardian, or grandparent with type II diabetes * Willing and able to consent to participation * Able to participate in group sessions after school or on Saturday mornings Adult * Samoan ethnicity * Diagnosed with type II diabetes at least 12 months prior to study enrollment * HbA1c \>= 6.5% * Prescribed medication (tablets or insulin) to control their diabetes * Willing and able to consent to participation * Willing and able to consent to adolescent's participation Exclusion Criteria: Adolescent * Planning to become pregnant during the study period (any adolescent who becomes pregnant will be excluded from analysis) * Planning to leave American Samoa in the next 18 months * Participants will be excluded if they report any of the following: * Uncontrolled hypertension (systolic \>180 mmHg or diastolic \>105 mmHg) * Heart attack, stroke, or transient ischemic attack in the past year * Treatment for cancer * Chest pain or shortness of breath with minimal activity * Chronic lung disease, or asthma requiring home oxygen therapy * Contraindications to moderate physical activity * Inability to read/speak Samoan and/or English. * Overt diabetes (HbA1c ≥6.5%) based on point-of-care testing during the screening process Adult * Planning to become pregnant during the study period (any adult who becomes pregnant will be excluded from analysis) * Planning to leave American Samoa in the next 18 months * Participants will be excluded if they report any of the following: * Uncontrolled hypertension (systolic \>180 mmHg or diastolic \>105 mmHg) * Heart attack, stroke, or transient ischemic attack in the past year * Treatment for cancer * Chest pain or shortness of breath with minimal activity * Chronic lung disease, or asthma requiring home oxygen therapy * Contraindications to moderate physical activity * Inability to read/speak Samoan and/or English.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes mellitus, type 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • OLaGA Research Center

    Pago Pago, American Samoa

More trials for these conditions

Other studies related to the condition(s) this trial covers.